WO2008077130A3 - Préparations homogènes de pâte et de gel - Google Patents

Préparations homogènes de pâte et de gel Download PDF

Info

Publication number
WO2008077130A3
WO2008077130A3 PCT/US2007/088225 US2007088225W WO2008077130A3 WO 2008077130 A3 WO2008077130 A3 WO 2008077130A3 US 2007088225 W US2007088225 W US 2007088225W WO 2008077130 A3 WO2008077130 A3 WO 2008077130A3
Authority
WO
WIPO (PCT)
Prior art keywords
optionally
provides
gel formulations
homogeneous paste
veterinary
Prior art date
Application number
PCT/US2007/088225
Other languages
English (en)
Other versions
WO2008077130A2 (fr
Inventor
Hassan Nached
Keith Freehauf
Peter Hanson
Original Assignee
Merial Ltd
Hassan Nached
Keith Freehauf
Peter Hanson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2006/048672 external-priority patent/WO2007075827A2/fr
Priority claimed from US11/713,881 external-priority patent/US20080027011A1/en
Application filed by Merial Ltd, Hassan Nached, Keith Freehauf, Peter Hanson filed Critical Merial Ltd
Priority to EP07869573A priority Critical patent/EP2101736A4/fr
Priority to CA2673193A priority patent/CA2673193C/fr
Priority to MX2009006656A priority patent/MX2009006656A/es
Publication of WO2008077130A2 publication Critical patent/WO2008077130A2/fr
Publication of WO2008077130A3 publication Critical patent/WO2008077130A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Cette invention concerne une préparation de pâte ou de gel pharmaceutique ou vétérinaire, qui peut comprendre: une quantité efficace d'un agent thérapeutique; éventuellement un absorbant ou un modificateur de viscosité; éventuellement un excipient hydrophile, un colorant, un stabilisant, un surfactif, ou un agent de préservation et éventuellement un antioxydant, un solvant, un aromatisant, un système tampon ou un épaississant; et des méthodes de fabrication de ces préparations. L'invention concerne également, entre autres, des pâtes ou des gels homogènes vétérinaires administrables par voie orale, destinés au traitement, à l'éradication et à la prévention d'infections par les endoparasites et les ectoparasites chez les animaux à sang chaud, tels que les oiseaux, les chevaux et les animaux de compagnie.
PCT/US2007/088225 2006-12-19 2007-12-19 Préparations homogènes de pâte et de gel WO2008077130A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP07869573A EP2101736A4 (fr) 2006-12-19 2007-12-19 Préparations homogènes de pâte et de gel
CA2673193A CA2673193C (fr) 2006-12-19 2007-12-19 Preparations homogenes de pate et de gel
MX2009006656A MX2009006656A (es) 2007-03-05 2007-12-19 Formulaciones homogeneas en pasta y gel.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
USPCT/US2006/048672 2006-12-19
PCT/US2006/048672 WO2007075827A2 (fr) 2005-12-20 2006-12-19 Formulations de pates homogenes
US11/713,881 2007-03-05
US11/713,881 US20080027011A1 (en) 2005-12-20 2007-03-05 Homogeneous paste and gel formulations

Publications (2)

Publication Number Publication Date
WO2008077130A2 WO2008077130A2 (fr) 2008-06-26
WO2008077130A3 true WO2008077130A3 (fr) 2008-08-21

Family

ID=40984939

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/088225 WO2008077130A2 (fr) 2006-12-19 2007-12-19 Préparations homogènes de pâte et de gel

Country Status (4)

Country Link
EP (1) EP2101736A4 (fr)
CA (1) CA2673193C (fr)
MX (1) MX2009006656A (fr)
WO (1) WO2008077130A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017310506B2 (en) 2016-08-11 2019-11-21 Dmk Pharmaceuticals Corporation Drug compositions
EP3720844A4 (fr) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation Compositions de médicaments
WO2019141771A1 (fr) * 2018-01-18 2019-07-25 Zoetis Broomhill Ip Limited Agents de scellement de trayons internes et leur utilisation dans la prévention de la mammite bovine chez la vache sèche
US10857151B1 (en) * 2020-02-21 2020-12-08 Villya LLC Treatment of female genital schistosomiasis

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
US6787342B2 (en) * 2000-02-16 2004-09-07 Merial Limited Paste formulations
US20050158252A1 (en) * 2003-12-22 2005-07-21 Radek Romanowski Method and compositions for oral hygiene
US20060239928A1 (en) * 2005-02-17 2006-10-26 Heit Mark C Transmucosal administration of drug compositions for treating and preventing disorders in animals

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6787342B2 (en) * 2000-02-16 2004-09-07 Merial Limited Paste formulations
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
US20050158252A1 (en) * 2003-12-22 2005-07-21 Radek Romanowski Method and compositions for oral hygiene
US20060239928A1 (en) * 2005-02-17 2006-10-26 Heit Mark C Transmucosal administration of drug compositions for treating and preventing disorders in animals

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2101736A4 *

Also Published As

Publication number Publication date
CA2673193A1 (fr) 2008-06-26
CA2673193C (fr) 2014-08-05
EP2101736A4 (fr) 2012-09-19
WO2008077130A2 (fr) 2008-06-26
EP2101736A2 (fr) 2009-09-23
MX2009006656A (es) 2009-08-07

Similar Documents

Publication Publication Date Title
WO2007075827A3 (fr) Formulations de pates homogenes
WO2004000034A3 (fr) Pates veterinaires homogenes orales anthelminthiques
MY145148A (en) Pharmaceutical formulation comprising an antibiotic, a triazole and a carticosteroid
CA2400317A1 (fr) Formulations pateuses ameliorees
WO2009087474A3 (fr) Agonistes pour des systèmes peptidiques antimicrobiens
CR8480A (es) Formulaciones veterinarias que contienen producto no animal
EP3587422A4 (fr) Composé dérivé de pyrrolo-pyrimidine, son procédé de préparation, et composition pharmaceutique comprenant ledit composé en tant que principe actif pour la prévention ou le traitement d'une maladie liée à la protéine kinase
EP1561457A3 (fr) Composition cosmétique à pouvoir d' hydratation cutanèe de longue durée
MX2013007500A (es) Formulacion de isoxazolina topica localizada.
CY1112106T1 (el) Σκευασματα παραθυρεοεiδους ορμονης και η χρηση τους
WO2009129352A3 (fr) Dispositif et procédé pour accéder aux canaux des glandes mammaires et les traiter
WO2010065747A3 (fr) Obturateur intramammaire de mamelle
WO2008077130A3 (fr) Préparations homogènes de pâte et de gel
EP3915991A4 (fr) Dérivé de pyrrolopyrimidine et composition pharmaceutique pour la prévention ou le traitement d'une maladie liée à la protéine kinase le comprenant en tant que principe actif
WO2015081319A3 (fr) Compositions de curcumine à activité améliorée et méthodes d'utilisation
WO2004089355A8 (fr) Compositions et procedes destines au traitement d'infections microbiennes et parasitaires affectant les bovins et autres animaux
CY1109541T1 (el) Φαρμακευτικη συνταγοποιηση για την θεραπεια οστεοαρθριτιδας η οποια περιεχει κλοδρονικο οξυ και υαλουρονικο οξυ
PE20151726A1 (es) Formulaciones veterinarias estables de combinacion de lactonas macrociclicas e imidazotiazoles
WO2008042557A3 (fr) Composition et procédé pour un shampooing pour animaux
WO2006087358A3 (fr) Composition permettant d'ajuster la qualite de l'eau pour administration de medicaments ou de vaccins sensibles a un sterilisateur d'eau
WO2009103901A3 (fr) Composition pharmaceutique contenant un derive de n-phenylpyrazole et du glycofurol, utilisation pour la preparation d'un medicament veterinaire topique pour lutter contre les puces
EP4023220A4 (fr) Composition pharmaceutique pour la prévention ou le traitement de maladies hépatiques choléstatiques, contenant de la beta-lapachone comme principe actif
WO2007022532A3 (fr) Composes cyclopropyles et compositions permettant de liberer des agents actifs
WO2007059422A3 (fr) Formulations pharmaceutiques contenant le 5-cyclopropyl-2(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl)amino]-n-methyl-1-benzofuran-3-carboxamide et procede de preparation de celles-ci
WO2019204363A3 (fr) Administration sélective d'agents thérapeutiques et d'imagerie

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07869573

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2673193

Country of ref document: CA

Ref document number: MX/A/2009/006656

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007869573

Country of ref document: EP